Engineered “mini livers” could be injected as an alternative to transplantation
A technology developed by Professor Sangeeta Bhatia, SM ’93, PhD ’97, and colleagues could offer new hope to the thousands of Americans with chronic liver disease who are waiting for an organ transplant or not strong enough to tolerate one. The liver is involved in regulating blood clotting, removing bacteria from the bloodstream, metabolizing drugs, and more, and many of these essential functions are performed by specialized cells called hepatocytes. Bhatia’s lab has been working for a decade o
The tech section covers stories about technology making life better, not just more profitable. Open-source tools reaching new audiences, accessibility breakthroughs, AI applications in healthcare and education, infrastructure improvements that quietly make cities work better. Product launches and funding rounds are excluded unless they deliver tangible public benefit.
Cambridge scientists say they have, for the first time, tested a vaccine designed by AI.
Researchers have developed a self-driving chemistry lab that can autonomously search through hundreds of catalyst recipe…
A new algorithm could drive breakthroughs in understanding cancer, Alzheimer's disease and other potentially fatal condi…
Our hands are the nimblest parts of our bodies, coordinating 34 muscles, 27 joints, and over 100 tendons and ligaments t…